These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 24469037)
41. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease. Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619 [TBL] [Abstract][Full Text] [Related]
42. Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation. Papp B; Motlagh N; Smindak RJ; Jin Jang S; Sharma A; Alonso JD; Toth Z J Virol; 2019 Mar; 93(5):. PubMed ID: 30541837 [TBL] [Abstract][Full Text] [Related]
43. Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication. Abere B; Samarina N; Gramolelli S; Rückert J; Gerold G; Pich A; Schulz TF J Virol; 2018 Sep; 92(17):. PubMed ID: 29950425 [TBL] [Abstract][Full Text] [Related]
44. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathway. Lee HR; Toth Z; Shin YC; Lee JS; Chang H; Gu W; Oh TK; Kim MH; Jung JU J Virol; 2009 Jul; 83(13):6739-47. PubMed ID: 19369353 [TBL] [Abstract][Full Text] [Related]
45. Oxidant species are involved in T/B-mediated ERK1/2 phosphorylation that activates p53-p21 axis to promote KSHV lytic cycle in PEL cells. Gonnella R; Yadav S; Gilardini Montani MS; Granato M; Santarelli R; Garufi A; D'Orazi G; Faggioni A; Cirone M Free Radic Biol Med; 2017 Nov; 112():327-335. PubMed ID: 28801242 [TBL] [Abstract][Full Text] [Related]
46. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus. Cathomas G Herpes; 2003 Dec; 10(3):72-7. PubMed ID: 14759339 [TBL] [Abstract][Full Text] [Related]
47. Modulation of Kaposi's sarcoma-associated herpesvirus infection and replication by MEK/ERK, JNK, and p38 multiple mitogen-activated protein kinase pathways during primary infection. Pan H; Xie J; Ye F; Gao SJ J Virol; 2006 Jun; 80(11):5371-82. PubMed ID: 16699017 [TBL] [Abstract][Full Text] [Related]
48. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication. Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712 [TBL] [Abstract][Full Text] [Related]
49. Role of heme oxygenase-1 in the pathogenesis and tumorigenicity of Kaposi's sarcoma-associated herpesvirus. Dai L; Qiao J; Nguyen D; Struckhoff AP; Doyle L; Bonstaff K; Del Valle L; Parsons C; Toole BP; Renne R; Qin Z Oncotarget; 2016 Mar; 7(9):10459-71. PubMed ID: 26859574 [TBL] [Abstract][Full Text] [Related]
50. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions. Paudel N; Sadagopan S; Chakraborty S; Sarek G; Ojala PM; Chandran B J Virol; 2012 Jun; 86(11):5974-91. PubMed ID: 22438557 [TBL] [Abstract][Full Text] [Related]
51. Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection. Naranatt PP; Krishnan HH; Svojanovsky SR; Bloomer C; Mathur S; Chandran B Cancer Res; 2004 Jan; 64(1):72-84. PubMed ID: 14729610 [TBL] [Abstract][Full Text] [Related]
52. Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells. Viollet C; Davis DA; Reczko M; Ziegelbauer JM; Pezzella F; Ragoussis J; Yarchoan R PLoS One; 2015; 10(5):e0126439. PubMed ID: 25942495 [TBL] [Abstract][Full Text] [Related]
53. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function. Si H; Robertson ES J Virol; 2006 Jan; 80(2):697-709. PubMed ID: 16378973 [TBL] [Abstract][Full Text] [Related]
54. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824 [TBL] [Abstract][Full Text] [Related]
55. Caspase-Mediated Cleavage of the Transcription Factor Sp3: Possible Relevance to Cancer and the Lytic Cycle of Kaposi's Sarcoma-Associated Herpesvirus. Chen LY; Chen LW; Hung CH; Lin CL; Wang SS; Chang PJ Microbiol Spectr; 2022 Feb; 10(1):e0146421. PubMed ID: 35019687 [TBL] [Abstract][Full Text] [Related]
56. Kaposi's Sarcoma-Associated Herpesvirus Fine-Tunes the Temporal Expression of Late Genes by Manipulating a Host RNA Quality Control Pathway. Ruiz JC; Devlin AM; Kim J; Conrad NK J Virol; 2020 Jul; 94(14):. PubMed ID: 32376621 [TBL] [Abstract][Full Text] [Related]
57. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication. Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M J Virol; 2017 May; 91(10):. PubMed ID: 28275189 [TBL] [Abstract][Full Text] [Related]